Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta-analysis

Journal of Hepatology

Volumn 26, Issue 2, 1997, Pages 312-324

  Bernard, Brigitte ^a   Lebrec, Didier ^b   Mathurin, Philippe ^a   Opolon, Pierre ^a   Poynard, Thierry ^a,c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b BEAUJON HOSPITAL   (France)

^c CNRS   (France)

Author keywords

cirrhosis; endoscopic sclerotherapy; meta analysis; prevention of rebleeding; propranolol

Indexed keywords

PROPRANOLOL;

ARTICLE; CLINICAL TRIAL; ENDOSCOPY; ESOPHAGUS VARICES BLEEDING; GASTROINTESTINAL HEMORRHAGE; HUMAN; LIVER CIRRHOSIS; META ANALYSIS; PRIORITY JOURNAL; RECURRENT DISEASE; SCLEROTHERAPY;

EID: 0031054019     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80047-5     Document Type: Article

References (36)

1. Pagliaro L, Burroughs AK, Sorensen TIA, Lebrec D, Morabito A, D'Amico G, Tinè F. Therapeutic controversies and randomized controlled trials (RCTs): prevention of bleeding and rebleeding in cirrhosis. Gastroenterol Int. 2:1989;71-84.
2. Poynard T. β-blockers should be used to prevent variceal bleeding? Gitnick G. Debates in Medicine. 2:1989;76-83 Year Book Medical Publisher, New York.
3. Hayes PC, Davis JM, Lewis JA, Bouchier IAD. Meta-analysis of value of propranolol in prevention of variceal haemorrhage. Lancet. 336:1990;153-156.
4. Pagliaro L, Burroughs AK, Sorensen TIA, Lebrec D, Morabito A, D'Amico GD, Tinè F. Beta-blockers for preventing variceal bleeding. Lancet. 336:1990;1001-1002.
5. Pignon JP, Poynard T, Naveau S, Chaput JC. Méta-analyse des essais randomisés des β bloquants dans la prévention des hémorragies digestives des sujets atteints de cirrhose (abstract). Gastroenterol Clin Biol. 12:1988;A175.
6. Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T. Meta-analysis of beta-blockers in the prevention of recurrent variceal bleeding in patients with cirrhosis (abstract). Hepatology. 20:1994;106A.
7. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: A meta-analytic review. Hepatology. 22:1995;332-354.
8. Infante-Rivard C, Esnaola S, Villeneuve JP. Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding: a meta-analysis. Gastroenterol. 96:1989;1087-1092.
9. Fleig WE, Stange EF, Hunecke R, Schönborn W, Hurler U, Rainer K, Gaus W, Ditschuneit H. Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: prospective, randomized comparison of propranolol and sclerotherapy. Hepatology. 7:1987;355-361.
10. Dollet JM, Champigneule B, Patrix A, Bigard MA, Gaucher P. Sclérothérapie endoscopique contre propranolol après hémorragie par rupture de varices œsophagiennes chez le cirrhotique. Résultats à 4 ans d'une étude randomisée. Gastroenterol Clin Biol. 12:1988;234-239.
11. Alexandrino PT, Alves MM, Pinto Correia J. Propranolol or endoscopic sclerotherapy in the prevention of recurrence of variceal bleeding. A prospective, randomized controlled trial. J Hepatol. 7:1988;175-185.
12. Westaby D, Polson RJ, Gimson AES, Hayes PC, Hayllar K, Williams R. A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding. Hepatology. 11:1990;353-359.
13. Andréani T, Poupon RE, Balkau B, Capron D, Desaint B, Barbare JC, Lagneau M, Grangé JD, Opolon P, Lévy VG, Poupon R. Efficacité comparée du propranolol et des scléroses endoscopiques de varices œsophagiennes dans la prévention des récidives d'hémorragies digestives au cours des cirrhoses. Etude controlée. Gastroenterol Clin Biol. 15:1991;A215. (Suppl 2).
14. Martin T, Taupignon A, Lavignolle A, Perrin D. Prévention des récidives hémorragiques chez les malades atteints de cirrhose. Gastroenterol Clin Biol. 15:1991;833-837.
15. Rossi V, Calès P, Burtin P, Charneau J, Person B, Pujol P, Valentin S, D'Aubigny N, Joubaud F, Boyer J. Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective, controlled trial of propranolol and sclerotherapy. J Hepatol. 12:1991;283-289.
16. Dasarathy S, Dwivedi M, Bhargava DK, Sundaram KR, Ramachandran K. A prospective, randomized trial comparing repeated endoscopic sclerotherapy and propranolol in decompensated (Child class B and C) cirrhotic patients. Hepatology. 16:1992;89-94.
17. Terés J, Bosch J, Bordas JM, Garcia Pagan JC, Feu F, Cirera I, Cirera I, Rodés J. Propranolol vs. sclerotherapy in preventing variceal rebleeding: A randomized controlled trial. Gastroenterol. 105:1993;1508-1514.
18. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analyses of randomized controlled trials. N Engl J Med. 316:1987;450-455.
19. Poynard T, Conn HO. The retrieval of randomized clinical trials in liver disease from the medical literature: a comparison of MEDLARS and manual methods. Controlled Clin Trials. 6:1985;271-279.
20. Pugh RNH, Murray-Lyon M, Dawson JL, Pietroni Mc, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 60:1973;646-649.
21. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta-blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 27:1985;335-371.
22. Der Simonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials. 7:1986;177-188.
23. Poynard T. Evaluation de la qualitédes essais thérapeutiques randomisés. Presse Med. 17:1988;315-318.
24. Qureshi H, Zuberi SJ, Alam E. Efficacy of oral propranolol and injection sclerotherapy in the long-term management of variceal bleeding. Digestion. 46:1990;193-198.
25. Westaby D, Melia W, Hegarty J, Gimson AES, Stellon AJ, Williams R. Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration. Hepatology. 6:1986;673-675.
26. Bertoni G, Fornaciari G, Beltrami M, Conigliaro R, Mortilla MG, Ricci E, Castagnetti E, Bedoni G, Planchet AC. Nadolol for prevention of variceal rebleeding during the course of endoscopic injection sclerotherapy: A randomized pilot study. J Clin Gastroenterol. 12:1990;364-365.
27. Gerunda GE, Neri D, Zangrandi F, Merenda R, Granzotto P, Ancona E, Battaglia G, Patarlenno E, Antoniozzi F, Primignani M, Vitagliano P, De Franchis R. Nadolol does not reduce early rebleeding in cirrhotics undergoing endoscopic variceal sclerotherapy (EVS): A multicenter randomized controlled trials (abstract). Hepatology. 12:1990;988.
28. Jensen LS, Krarup N. Propranolol may prevent recurrence of œsophageal varices after obliteration by endoscopic sclerotherapy. Scand J Gastroenterol. 25:1990;352-356.
29. Lundell L, Leth R, Lind T, Lonroth H, Sjavall M, Olbe L. Evaluation of propranolol for prevention of recurrent bledding from esophageal varices between sclerotherapy sessions. Acta Chir scand. 156:1990;711-715.
30. Vinel JP, Lamouliatte H, Cales P, Combis JM, Roux D, Desmorat H, Pradere B, Barjonnet G, Quinton A, Pascal JP. Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration. Gastroenterology. 102:1992;1760-1763.
31. Acharya SK, Dasarathy S, Saksena S, Pande JN. A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy. J Hepatol. 19:1993;291-300.
32. Avgerinos A, Rekoumis G, Klonis C, Papadimitriou N, Gouma P, Pournaras S, Raptis S. Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial. J Hepatol. 19:1993;301-311.
33. Vickers C, Rhodes J, Chesner I, Hillenbrand P, Dowson J, Cockel R, Adams D, O'Connor H, Dykes P, Bradby H, Valori R, Elias E. Prevention of rebleeding from oesophageal varices: two-year follow up of a prospective controlled trial of propranolol in addition to sclerotherapy. J Hepatol. 21:1994;81-87.
34. O'Connor KW, Lehman G, Yune H, Brunelle R, Christiansen P, Hast J, Compton M, McHenry R, Klatte E, Cockerill E, Holden R, Becker G, Kopercky K, Hawes R, Pound D, Rex B, Lui A, Snodgrass P, Weddle R, Crabb D, Lument L. Comparison of three nonsurgical treatments for bleeding esophageal varices. Gastroenterology. 96:1989;899-906.
35. Ink O, Martin T, Poynard T, Reville M, Anciaux ML, Lenoir C, Marill JL, Labadie H, Masliah C, Perrin D, Chaput JC, Vetter D, Eugene C, Lebodic L, Hicht H, Etienne JP. Does elective sclerotherapy improve the efficacy of long term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter randomized trail. Hepatology. 16:1992;912-919.
36. Fleig WE, Stange EF, Hunecke R, Schönborn W, Ditschuneit H. Propranolol (P) vs. endoscopic sclerotherapy (EPS) for the prevention of recurrent hemorrhage in cirrhosis: final analysis of a randomized clinical trial. J Heptaol. 7:((S)):1988;S32.